GA231000: Fmoc-Thr(GlcNAc(Ac)3-β-D)-OH Pack Size:50 mg 2-Thioethyl β-D-lactopyranoside

2-Thioethyl β-D-lactopyranoside

Galα(1-3)Galβ(1-4)GlcNAc-β-O-(CH2)4-COOH

68 / / 1-α-Hydroxy Vitamin D3-d6 / 1α-Hydroxycholecalciferol-d6

α-L-Rha-Et-NH2

This compound enables the construction of lysosome-targeted therapeutics and research tools that exploit the mannose-6-phosphate receptor (M6PR)

GA231000: Fmoc-Thr(GlcNAc(Ac)3-β-D)-OH Pack Size:50 mg 2-Thioethyl β-D-lactopyranosideC33H38N2O13 670. 66 An Fmoc protected L threonine building block carrying a D GlcNAc residue, designed for solid phase peptide synthesis (SPPS) of glycopeptides. The N Fmoc group is removed under standard base conditions (piperidine) during chain elongation, while the free carboxylic acid is available for coupling to the growing resin bound peptide. The sugar hydroxyl groups are protected as three acetate esters (Ac3), which keep the glycan inert